- Research article
- Open Access
Optic nerve crush induces spatial and temporal gene expression patterns in retina and optic nerve of BALB/cJ mice
Molecular Neurodegeneration volume 9, Article number: 14 (2014)
Central nervous system (CNS) trauma and neurodegenerative disorders trigger a cascade of cellular and molecular events resulting in neuronal apoptosis and regenerative failure. The pathogenic mechanisms and gene expression changes associated with these detrimental events can be effectively studied using a rodent optic nerve crush (ONC) model. The purpose of this study was to use a mouse ONC model to: (a) evaluate changes in retina and optic nerve (ON) gene expression, (b) identify neurodegenerative pathogenic pathways and (c) discover potential new therapeutic targets.
Only 54% of total neurons survived in the ganglion cell layer (GCL) 28 days post crush. Using Bayesian Estimation of Temporal Regulation (BETR) gene expression analysis, we identified significantly altered expression of 1,723 and 2,110 genes in the retina and ON, respectively. Meta-analysis of altered gene expression (≥1.5, ≤-1.5, p < 0.05) using Partek and DAVID demonstrated 28 up and 20 down-regulated retinal gene clusters and 57 up and 41 down-regulated optic nerve clusters. Regulated gene clusters included regenerative change, synaptic plasticity, axonogenesis, neuron projection, and neuron differentiation. Expression of selected genes (Vsnl1, Syt1, Synpr and Nrn1) from retinal and ON neuronal clusters were quantitatively and qualitatively examined for their relation to axonal neurodegeneration by immunohistochemistry and qRT-PCR.
A number of detrimental gene expression changes occur that contribute to trauma-induced neurodegeneration after injury to ON axons. Nrn1 (synaptic plasticity gene), Synpr and Syt1 (synaptic vesicle fusion genes), and Vsnl1 (neuron differentiation associated gene) were a few of the potentially unique genes identified that were down-regulated spatially and temporally in our rodent ONC model. Bioinformatic meta-analysis identified significant tissue-specific and time-dependent gene clusters associated with regenerative changes, synaptic plasticity, axonogenesis, neuron projection, and neuron differentiation. These ONC induced neuronal loss and regenerative failure associated clusters can be extrapolated to changes occurring in other forms of CNS trauma or in clinical neurodegenerative pathological settings. In conclusion, this study identified potential therapeutic targets to address two key mechanisms of CNS trauma and neurodegeneration: neuronal loss and regenerative failure.
Central nervous system (CNS) trauma and neurodegenerative disorders trigger a cascade of cellular events resulting in extensive damage to neurons [1–5]. The non-permissive regenerative environment is due to expression of inhibitory cues [3, 6–12], glial scarring [5, 13], slow clearance of axonal debris , and CNS inflammation [15, 16]. Regenerative failure is a critical endpoint of these destructive triggers culminating in neuronal apoptosis [3, 17, 18] and inhibition of functional recovery.
The rodent optic nerve crush (ONC) model is an effective model for CNS trauma and regeneration failure [19–25]. The easy accessibility of the optic nerve (ON), an extension of the CNS, and the reproducibility of the ONC model make it an effective tool to study CNS trauma. Changes in gene expression in rodent ONC models have been previously studied [22, 26–30] and include gap associated protein 43 (Gap43) [31–33], glial fibrillary acidic protein (Gfap) [34–36] and neurofilament deregulation after crush injury . Furthermore, progressive retinal ganglion cell (RGC) degeneration has been associated with loss of trophic support [38, 39], stimulation of inflammatory processes/immune regulation [40, 41], and apoptotic effectors [39, 42–45]. In addition, multiple injury models have been utilized to assess the fate of RGCs after ocular injuries that include ischemia/reperfusion, ON irradiation, ON transections, and traumatic ON injury in rodent and primate models [22, 30, 46–50].
Although previous studies with CNS trauma models have addressed gene expression changes related to neuronal apoptosis [18, 26, 39, 51], current gaps still exist for identifying long-term neuroprotective and regeneration inducing targets. Additionally, most expression studies for the ONC model have only been performed in the retina or the optic nerve head [3, 22, 29]. We adopted a distinct strategy from previously published literature by: (a) simultaneously focusing on both the retina and ON, (b) detailing an extended time-course after acute axonal trauma and (c) centering on neurodegeneration and regenerative failure. To pinpoint specific degenerative pathways and identify crucial genes involved with pathological axonal injuries, it is essential to create an extensive molecular gene profile underlying neuronal degeneration and regeneration failure mechanisms. Our study systematically and temporally identified these degenerative mechanisms that ensue after such an insult. To prevent the progression of the disease, new drug therapies geared towards neuroprotection and effective axonal regeneration are required. The purpose of this study was to detect and quantify progressive temporal degenerative changes by: (a) analyzing gene clusters in the retina and ON using Affymetrix microarrays in the neural, immune, and glial cells following ONC and (b) identifying temporal and spatial expression patterns of key gene targets within the retina and ON after trauma. These data will allow the identification of a wide range of potential therapeutic targets associated with neuronal loss and regenerative failure.
This study highlights common as well as distinct gene expression responses of the retina and ON to ONC injury. To better understand the molecular mechanisms associated with neurodegenerative processes after injury, we first examined the survival of neurons in the ganglion cell layer (GCL) after acute axonal trauma by histological examination of the retinas over an extended 28-day period, which is a well-established time line for RGC death . Second, we identified significant cluster-based changes occurring sequentially in the retina and ON by meta-analysis of the array data. Third, we identified key clusters associated with neuron degeneration to isolate potential underlying damaging gene expression changes occurring within the retina and ON. Lastly, the expression of selective genes was confirmed quantitatively and qualitatively to validate our array data and examine expression of potential therapeutic targets that are affected by CNS trauma.
Survival of neurons and specificity of gene expression changes following ONC
There was a progressive decrease of neurons in the retinal ganglion cell layer (RGCL) following ONC as assessed by Nissl stained retinal flat mounts (Additional file 1: Figure S1A). Approximately 50% of the cells in the RGCL are RGCs, while the remaining cells consist of displaced amacrine cells, astrocytes, and microglia [19, 52–55]. ONC directly damages the ON, eventually leading to the selective death of RGCs. The severity of injury to the RGCs after ONC can vary between studies and depends on: the species and strain of animal used, the quantity of axons affected by the crush, the distance from the globe at which the lesion is performed, the amount of force applied at the site of the lesion, the method used to evaluate damage, and the length of time post crush [37, 46, 56–58]. A significant sequential decline of RGCL neurons is seen as early as 14 days post crush (dpc) within our model (81.43% ± 16.9% survival, p < 0.01) with increased decline by 21 dpc (58.72% ± 5.70% survival, p < 0.001) and culminating in almost complete loss of RGCs by 28 dpc (54.21% ± 8.27% survival, p < 0.001) (Additional file 1: Figure S1B).
Microarrays were performed following ONC on harvested retina and ON samples from naïve, 3, 7, 14, 21 and 28 dpc mice (n = 5). For the analysis, the retina and ON samples were separately pooled for the experimental and control groups at each time point. Time-course microarray data analysis is challenging in pooled data because each sample has slight variations independent of other samples. These errors can be mitigated to an extent by analyzing the significant temporal changes of genes in pooled samples using the Bayesian estimation of temporal regulation (BETR) analysis . This evaluation allowed us to delineate the differences in percentage of gene changes occurring temporally after ONC within the retinal and ON datasets. BETR probabilities were determined for the total 18,786 genes identified within each dataset. BETR probabilities ranged from 0 to 1 with 0 being the least significantly changed genes temporally and 1 being the most. Genes were then classified into frequency bins based on the range of BETR probabilities.
In the retinal dataset, only 9.17% (1,723 genes out of 18,786 genes) had the highest BETR probabilities within frequency bin 10 (BETR probability - 0.9 to1.0) indicating only a small specific percentage of total genes were altered temporally after ONC trauma (Additional file 2: Figure S2A, Additional file 3: Table S1A). Furthermore, within the ON dataset, only 11.23% (2,110 genes out of 18,786 genes) were in the highest BETR probability range (Additional file 2: Figure S2B, Additional file 3: Table S1B). The small subset of genes identified by BETR analysis correlates with regenerative failure and degeneration that occurs within the retina and ON.
Cluster specific gene classification following ONC
To extract meaningful biological information from the array data, we used the public data-mining tool Database for Annotation, Visualization and Integrated Discovery (DAVID) to cluster all differentially expressed genes into mechanistic biological categories. Temporal cluster classification is crucial for identifying the neuronal loss mechanisms that are sequentially regulated after trauma. Based on PARTEK fold change levels (≥ 1.5 and ≤ −1.5 compared to the corresponding contralateral control eyes, q-value defined by the FDR analogue of the p < 0.05), we temporally categorized the clusters within three gene ontologies (GO); molecular function (MF), biological process (BP) and cellular component (CC) according to the Mus musculus genome within the DAVID database.
A total of 28 up-regulated clusters and 20 down-regulated clusters were significantly identified in the retinal dataset (p < 0.05) and 57 up-regulated clusters and 41 down-regulated clusters were identified within the ON dataset (Tables 1, 2, 3 and 4). To outline neurodegenerative mechanisms, key clusters were identified relating to neuronal loss and regeneration failure from both the retinal (Figure 1) and ON (Figure 2) clusters previously classified in Tables 1, 2, 3 and 4. Each of these key clusters contained a group of genes significantly (p < 0.05) correlating with that specific cluster. The temporal patterns of the microarray gene ratios were graphed according to their association with these clusters for the retina (Figure 1) and ON (Figure 2).
Retinal clusters associated with neuronal loss and regeneration failure included the clusters neuron projection, regulation of axonogenesis, neuron projection morphogenesis, neuron differentiation and axon clusters (Figure 1). Of particular interest was the gene Neuritin 1 (Nrn1), which was identified within the neuron projection morphogenesis and neuron differentiation clusters (Figure 1C, D). NRN1 is a secreted GPI-linked protein that stimulates axonal and dendritic arbor growth . Down-regulation of Nrn1 mRNA expression within the microarray was observed to be biphasic with an initial decline through 7 dpc, a slight increase at 14 dpc and a further decrease by 21 dpc (Figure 1C, D). These biphasic patterns may indicate a transient attempt at neuroprotection/neuroregeneration early in the response to injury.
ON clusters associated with neuronal loss and regeneration identified from the ON cluster tables (Tables 3 and 4) included positive regulation of axonogenesis, regulation of synaptic plasticity, neuron projection, synaptic transmission and neurofilament cytoskeleton organization (Figure 2).
Neuron projection and synaptic transmission clusters both identified key genes called synaptotagmins (Syt) that participate in axonal regeneration, including synaptic projection and proper axonal targeting. Expression of Syt genes was elevated in the ON at 21 dpc (Figures 2C, D).
By analyzing the retina and ON simultaneously, we were able to observe the temporal response of gene expression in the retina and ON individually as well as in comparison to each other. Neurofilament (NF) genes were identified in most of the retinal and optic nerve clusters. Decreased expression of neurofilament medium (Nefm) and light chain (Nefl) genes in the retina at 3 and 21 dpc (Figure 1) preceded neuronal loss after axonal damage (Additional file 1: Figure S1B). However, by 28 dpc Nefm and Nefl expression was elevated in the ON (Figures 2C and E). This pattern of NF expression is consistent with previous studies identifying NF dysregulation during neurodegeneration [61–74].
Validation of key target genes having differential expression by qRT-PCR
Analysis of pooled microarray samples does not account for the potential variations that exist between samples and may mask individual sample differences. To confirm individual samples follow the same trend of expression as the microarray data, we used qRT-PCR to determine the expression levels of target genes in each sample. For the retina, we verified two genes (Nrn1 and Vsnl1) that have been previously identified as RGC markers [75, 76]. Nrn1 had similar expression patterns as Vsnl1 (Figure 3A and B, respectively), and expression of each gene was significantly correlated with the corresponding microarray ratios (Nrn1 R2 = 0.96, Vsnl1 R2 = 0.73) (p < 0.05) (Additional file 4: Tables S2A and B). Both genes displayed a biphasic level of expression with significantly decreased expression from basal naïve levels at 3 and 21 dpc and modestly decreased expression at 14 dpc (p < 0.05, n = 5) (Figure 3).
In the ON dataset, Nrn1, synaptotagmin 1 (Syt1) and synaptoporin (Synpr) expression levels were validated by qRT-PCR. We observed significantly increased expression of Nrn1 at 28 dpc versus all time-points (p < 0.05, n = 5) (Figure 4A). The qRT-PCR results significantly correlate with the microarray data (R2 = 0.86, p < 0.05) (Additional file 4: Tables S2A and B). Syt1 expression was significantly up-regulated at 21 dpc (p < 0.05, n = 5), in contrast to all the other time points (Figure 4B). These results were similar to Syt1 microarray ratios, in which Syt1 expression was elevated only at the 28 dpc period. The shift in the time course of gene up-regulation is most likely due to various individual samples that were masked in the pooled microarray samples. Therefore, the linear regression correlation between both sets of data was less than 0.5 (R2 = 0.07) (Additional file 4: Tables S2A and B). Increased expression of synaptoporin (Synpr) was observed at 28 dpc (Figure 4C) and correlated significantly with gene microarray ratios (R2 = 0.71, p < 0.05, n = 5) (Additional file 4: Table S2B). Expression of Synpr has been shown in neurons while Syt1 has been shown in both neurons and is critical in fusion events of astrocytes [77–81]. In addition to synapse formation, Syt1 has also been shown to regulate the formation of axonal filopodia and branching . The induction of both Synpr and Syt1 expression may be related to synaptic vesicle fusion and release, and the roles of both genes in ONC need to be further explored.
Immunohistochemical analysis of validated gene targets
Whole retinas were utilized for microarray analysis, potentially masking the changes specific to the RGCs, as they comprise only about 0.5% of the whole retina . To determine temporal protein expression patterns occurring specifically within the RGCs of the GCL, we performed retinal immunostaining. We first tested the expression of Brn3a (brain-specific homeobox/POU domain protein 3A), a well-known marker for RGCs [57, 83, 84]. As expected, we observed a progressive decrease in Brn3a expression after ONC within the GCL (Figure 5A and D). These results demonstrate a temporal decline in RGCs after axonal injury.
Retinal immunostaining for Vsnl1 and Nrn1 proteins confirmed apparent temporal changes in protein expression after ONC. Within the naïve retinal sections, approximately 50% of the GCL cells were positive for Vsnl1/Brn3a and 47% were positive for Nrn1/Brn3a (Figure 5E and F). A biphasic protein expression pattern was observed for Vsnl1 with decreased expression in the nerve fiber layer (NFL) and inner plexiform layer (IPL) at 7 dpc, increased expression at 14 dpc compared to the naive retina, and a complete loss of expression by 28 dpc (Figure 5B). Focusing on the GCL, the staining pattern also changed at 7 dpc and became more cytoplasmic, in contrast to the diffuse pattern observed in the naïve retinas (Figure 5E). These data verify the Vsnl1 mRNA expression data (Figure 3A).
A similar biphasic expression pattern was observed for Nrn1 with peak expression at 14 dpc (Figure 5C) and increased nerve fiber layer staining pattern with the GCL at 7 dpc (Figure 5F). Compared to Vsnl1, Nrn1 immunostaining was observed in the ganglion cells and NFL, but not as extensively within the IPL. In addition, previous studies of retinal Nrn1 in-situ hybridization exhibited predominant expression within the ganglion cell layer , which agrees with our IHC study.
Temporal Syt1, Synpr and Nrn1 protein expression patterns were determined in longitudinal sections of the ON. Images were examined at each time point for each protein as represented by Figure 6A. At 7 dpc, all proteins were individually co-labeled with Nfl to show localization of the axons and the pattern of staining for each protein within the ON (Additional file 5: Figure S3 G-I). The expression pattern of Synpr and Nrn1 was not as intense as Syt1 (Additional file 5: Figures S3 G-I) but still colocalized with Nfl staining. In contrast, the staining pattern of Syt1 colocalized with Nfl and also within the cells surrounding the ON axons (Additional file 5: Figure S3 G). Increased expression of Syt1 was evident at 14, 21 and 28 dpc (Figure 6B and C). Elevated levels of Syt1 were seen within the cytoplasmic region of ON cells through the time course post crush (Figure 6B). Synpr protein expression within the ON was evident at 21 and 28 dpc (Figure 6D and E). Similar to Syt1 expression, Synpr cytoplasmic staining was observed within the ON cells (Figure 6D). The temporal protein expression pattern of Syt1 and Synpr followed the mRNA expression patterns (Figure 4B and C).
In contrast to Syt1 and Synpr, Nrn1 ON protein expression levels (Figure 6F and G) did not match mRNA expression data (Figure 4A). Increased expression of Nrn1 was observed at 14 and 21 dpc (Figure 6F), while increased mRNA expression was observed at 28 dpc (Figure 4A). The offset in the time course for protein expression compared to mRNA expression can be expected due to both mRNA half-life stability and rates of protein synthesis to degradation.
Signaling pathways involved in RGC degeneration are quite complex, and identifying correct target molecules that can mitigate neuronal degeneration and failed regeneration are necessary to develop new neuroprotection strategies. We utilized the ONC mouse model to understand the mechanisms involved in RGC death. ONC directly damages the ON, leading to a progressive loss of RGCs. We identified temporal gene expression changes in the retina and ON after ONC. Key genes associated with neuronal loss and regenerative failure were identified in both retina and ON, and the expression changes were validated by qRT-PCR and immunostaining.
Previously it has been shown that genetic background has an influence on susceptibility to neuronal damage in different inbred mouse lines after neurodegenerative stimuli . C57BL/6 mice are more resistant to ONC, while BALB/c mice are more susceptible to this axonal injury. However, both strains display similar susceptibility to spinal cord injury [20, 86]. The differences observed between strains could be partly due to variability in immune response, differences in neuronal stress pathways, and/or activation of alternate cell death pathways [20, 87]. In addition, albino rodents are more susceptible to light-induced retinal damage, causing photoreceptor cell death and subsequent retinal degeneration [88, 89]. However, retinal degeneration not induced by external factors has not been previously reported in BALB/cJ mice. Thus, our BALB/cJ ONC model is extremely useful for studying the potential mechanisms underlying neuronal cell death due to its susceptibility to crush injury.
Previous ONC studies have observed changes in gene expression within the retina [22, 46, 90–93] and glial based responses within the ON . Analyzing the retina and ON simultaneously allowed the identification of individual clusters related to neuronal loss and regenerative failure within each tissue separately as well as allowed us to observe the temporal response of gene expression occurring in both the ON and retina with progressive injury to these two tissues.
Neurofilament genes were identified in both the retina and ON datasets. Atypical accumulations of NFs are associated with several neurodegenerative disorders [61–74], and dysregulation of NFs and NF aggregation accompany axonal damage after CNS trauma. NFs have also been associated with CNS diseases and axonal degenerative processes . We show temporal differences in neurofilament expression between the retina and ON suggesting crucial gene changes occur after trauma in the retina and ON. There is progressive decline of retinal Nfl expression compared to the elevated expression within the ON out to 28 dpc. These results are consistent with a model in which axonal damage precedes retinal neuronal degeneration and accumulation of damage associated genes occurs within the ON before soma degeneration. The changes in expression patterns identified in our ONC model correlate with previous studies identifying NF dysregulation during neurodegeneration [61–74].
The RGCL comprises multiple cell types including RGCs, amacrine cells, astrocytes, microglia, and vascular cells that interact with the RGC somas. After ONC, these cells also initiate degenerative pathways causing RGC apoptosis [95, 96]. Thus, the deregulation of genes observed within the retina is not restricted to RGCs and also represent gene expression of the surrounding cells. Glial fibrillary acidic protein (Gfap), a marker of astrogliosis, is up-regulated after CNS trauma and is used as a universal index of retinal injury [34, 96]. Gfap is initially up-regulated after ONC [35, 36] and showed a similar expression pattern in our retinal dataset. After injury of CNS axons, glial responses around the affected area are increased, and this may contribute to trauma-induced neurodegeneration . By identifying key clusters associated with degeneration of neurons and axonopathy, we were able to isolate potential target genes (Vsnl1, Nrn1, Syt1, Synpr).
Vsnl1 gene is a member of the neuronal subfamily of EF-hand calcium sensor proteins. These proteins play vital roles in cellular signal transduction and neuroprotection/neurotoxicity and have been implicated in neurodegenerative diseases [98, 99]. Vsnl1 is predominantly expressed in isolated immuno-panned rat RGCs  and has also been shown to specifically label the inner retina (amacrine and RGCs) and the inner plexiform layer of rat, chicken, and bovine retinas . In our study, expression of the Vsnl1 gene was down-regulated after ONC, which may prevent the survival of RGCs. Although the precise functional roles of Vsnl1 are still unclear, Vsnl1 proteins may play key roles in membrane trafficking, neuronal signaling, and differentiation . As ON axonal transport is inhibited after ONC, decreased levels of Vsnl1 may contribute to the deleterious effects on axonal transport mechanisms seen in ONC.
Functionally, Nrn1 acts as a ligand to the insulin receptor  and cleavage of the GPI anchor by phospholipase C allows the soluble secreted form to be cell independent . The GPI membrane bound anchor of Nrn1 allows growth promotion as it can stimulate axonal plasticity, dendritic arborization, and synapse maturation in the CNS [60, 102]. Conditional knockout of the Nrn1 gene delays development, maturation of axons and dendritic arbors, synaptic maturation, and effective learning . Neurotrophins such as nerve growth factor (NGF), brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) as well as neuronal activity can potentiate the expression of Nrn1[104, 105]. NGF induces expression of Nrn1, which increases neurite outgrowth in a variety of experimental models [104, 106, 107]. Our studies suggest that after axonal insult, RGCs initially increase Nrn1 expression for axonal regeneration to overcome obstructed transport mechanisms. These regenerative supportive mechanisms are lost 14 dpc because by then most of the RGCs have been damaged, and the survival of these neurons has progressively decreased. The correlation of retinal protein expression of Nrn1 at 14 dpc mimics the elevated expression of Nrn1 at the same time-point within the ON. Taken together, these data suggest that the dynamic regulation of Nrn1 may be an effort for axonal regeneration after ONC.
The relative abundance of protein expression may not be proportional to the relative mRNA levels. This lack of correlation in mRNA and protein expression levels could be due to mRNA stability and/or rates of protein synthesis and/or degradation. The slight increase in retinal mRNA expression at 14 dpc (compared to 3 and 7 dpc) is maybe increasing the translation of the Nrn1 within the RGCs soma and Nfl, which is then transported downstream to the ON axons.
The optic nerve includes not only the axons of the RGCs but also astrocytes, microglia, and oligodendrocytes that interact with RGC axons as well as each other . Thus, the expression of genes observed within the ON may represent the beneficial or detrimental effects of neighboring cells surrounding the RGC axons. Differentially regulated genes within the ON expression microarray also identified other key genes associated with synaptic transmission (Syt1 and Synpr) and synaptic plasticity gene (Nrn1) that participate in axonal regeneration, including synaptic projection, and proper axonal targeting.
A collection of signaling mechanisms link both axonal tips and dendritic terminals to neuronal soma and nucleus by motor-dependent transport machineries. Signaling complexes could be transported either in endosomes, or as non-endosomal complexes associated with importins and dynein . Essential membrane components of synaptic vesicles and synaptic transmission associated proteins are translated in the soma and get transported to the growing distal ends of extending neurites after crush injury [109, 110]. In addition, synaptic vesicles are localized to small vesicles within the neuron, particularly in neuronal axonal processes . Eventually, as axonal transport is inhibited after ONC due to glial scarring [5, 13], there is decreased transport of proteins involved in neuroprotection and synaptic plasticity. This causes deleterious effects, eventually leading to decreased synaptic plasticity and transmission at distal ends.
Syt proteins act as synaptic calcium sensors for vesicle fusion in conjunction with SNAREs that facilitate intracellular membrane fusion events [112–114]. Syts have a conserved mechanism of action and are crucial for neuronal Ca2+-triggered vesicle fusion . Previous studies have shown Syt1 to participate in axonal regeneration, including synaptic projection and proper axonal targeting [80, 116]. In our study, Syt1 was identified in ON neuron projection and synaptic transmission clusters. It appears that the ON attempts to initiate synaptic projection following ONC trauma as shown by the biphasic mRNA and protein expression of Syt1.
Similarly, Synprs are essential membrane components of synaptic vesicles . Synpr has restricted distribution within the CNS and is present in the telencephalic structures, hippocampus, olfactory bulb, and retina [77, 117–119]. Synpr plays potential roles in the modulation of synaptic transmission and specificity to neuronal circuitry . Increased protein expression of Synpr in the ON was observed at 21 and 28 dpc. The induction of both Synpr and Syt1 expression may be related to synaptic vesicle fusion and release. After trauma, these synaptic vesicles get transported to the growing distal ends of extending neurites [109, 110]. Eventually, as the RGCs are trying to overcome regenerative failure, they may increase expression of Syt proteins within their axons in attempt to induce synaptic plasticity and transmission at distal ends. Elevated expression of Synpr and Nrn1 suggests they are mediating synaptic differentiation as synaptic organizing proteins, but the deregulation of mRNA expression and eventually protein expression may be a futile attempt at ON regeneration in late pathogenesis.
We have explored temporal gene expression changes after ONC axonal injury that can be extrapolated to other CNS traumas. Although there are gene expression differences between the retina and brain, similar differences also occur within discrete regions of the brain as each part of the brain has different motoric, sensory, and cognitive functions. For example, gene expression in the cerebellum differs the most from the other regions of the brain [120, 121] and has also been reported in inbred strains of mouse brain . In addition, inter-individual differences have also been reported within a species . As is the case while studying any trauma or disease model, only a generic evaluation can be made in terms of relevance to other regions in the CNS. In conclusion, the ONC model has identified two key mechanisms of CNS trauma and neurodegeneration: neuronal loss and regenerative failure. Dysregulation of Vsnl1, Syt1, Synpr and Nrn1 gene expression may play an important role in neurodegeneration and potentially provide unique targets for intervention.
The current study delineates the gene expression profile associated with neurodegeneration and regenerative failure after ONC-induced CNS trauma. CNS trauma causes degeneration of neurons and axonopathy, which is evident in neurodegenerative diseases such as Parkinson’s, Alzheimer’s, and glaucoma [1–5]. The susceptibility of the neurons to acute axonal injury allowed the identification of gene expression changes that occur before neuronal loss. Using the reproducible ONC model of CNS trauma, we were able to: (a) examine gene expression changes within the retina and ON, and (b) visualize protein expression patterns of key selected genes associated with neuron loss and regenerative failure within the retina and ON after ONC. BETR analysis of microarray gene expression data was utilized to show that a select small subset of genes was affected at multiple time points following ONC. Bioinformatic meta-analysis identified gene clusters associated with regenerative changes, synaptic plasticity, axonogenesis, neuron projection, and neurodegeneration. A neurite synaptic plasticity gene (Nrn1), synaptic vesicle fusion genes (Synpr and Syt1), and neuron differentiation associated gene (Vsnl1) were a few of the key temporally regulated genes identified in our study. In conclusion, analysis of these gene arrays and protein expression patterns allowed the detection, quantification and visualization of key differentially regulated genes after ONC. This study has identified potential pathogenic genes and possible new therapeutic targets to address two key mechanisms of CNS trauma: neuronal loss and regenerative failure.
BALB/cJ mice aged 2–4 months were utilized for all the experiments and were obtained from the Jackson Laboratories (Bar Harbor, ME). The mice were housed and maintained in a 12-hour light/dark cycle and fed ad libitum. All procedures were performed in accordance with Association for Research in Vision and Ophthalmology Statement on the Use of Animals in Ophthalmic and Vision Research and the University of North Texas Health Science Center (UNTHSC) Institutional Animal Care and Use Committee regulations (IACUC protocol # 2011/2012-58-A04, approved October 8th 2012).
Mice were divided into three separate groups according to the experiment. The time course of the ONC included six different time-points (naïve (0), 3, 7, 14, 21 and 28 dpc). To determine the percentage of neurons surviving after crush, 8–9 mice per time-point were used for retinal Nissl staining. For the microarray studies and qPCR validation, 5 mice were used per time-point. After the retinal and ON tissues were harvested, the samples were divided into two parts. cDNA was made from half of each individual sample for qPCR validation, while the remaining portion of samples were pooled to generate one sample for each experimental time point. Microarray analysis was performed on control and ONC retina and ON samples for each time point. To qualitatively identify protein expression, three mice per time-point were utilized for IHC.
Optic nerve crush model
The ON of the left eye was crushed 0.5 mm posterior from the globe for 4 seconds using the Nickell’s technique . Briefly, mice were anesthetized by intraperitoneal injection of ketamine (100 mg/kg) and xylazine (10 mg/kg) and an incision was made along the superior orbital margin. The ON (left) was exposed and crushed using a self-closing jeweler’s forceps to ensure reproducibility and constant force. Extreme care was taken not to damage the ocular blood vessels. Indirect ophthalmoscopy was performed to ensure retinal circulation was not blocked. The contralateral eye was used as the uncrushed control.
Characterization of optic nerve crush model
To quantify cell loss from the retinal RGCL, retinas from fixed eyes were dissected, flat mounted and Nissl stained with cresyl violet stain as previously described [19, 87, 123]. Eyes were fixed in 4% paraformaldehyde in phosphate buffered saline (PBS; 0.1M phosphate and 100mM NaCl buffer (pH 7.4)) for an hour at room temperature. After fixation, the eyes were rinsed with PBS, and the posterior cup isolated and placed in 0.3% Triton-X 100 PBS for 16 hours at 22°C. The tissues were then placed in 3% H2O2 and NaH2PO4 overnight. The retinas were dissected, cut into four quadrants, and mounted RGC side up on positively charged glass slides (Fisher Scientific, Chicago, IL). The slides were then air dried and flattened with coverslips using 10 g weights. The dried retinas were stained with 1% cresyl violet acetate in 0.25% acetate for 30–45 seconds. After staining, the retinas were dehydrated in 90% and 100% ethanol and cleared with xylene to reduce background staining and mounted with a coverslip.
To determine the density of remaining RGCL neurons within each retina, two digital images from each quadrant (peripheral and mid-peripheral region - four quadrants/retina) were captured at 400 X magnification. A total of 8 images per retina were counted using Adobe Photoshop software. Cell counts were analyzed by comparing the experimental retinas against the contralateral control retinas (cell counts ± SD) at each time point. Quantification of percentage neuron survival following ONC from 3 to 28 dpc was performed. Data points (Additional file 1: Figure S1 B) represent mean ± SD of surviving neurons after crush normalized to contralateral control eyes. Statistics were determined using one-way ANOVA -Tukey post hoc test, ** p < 0.01, *** p < 0.001, n = 8-9 eyes/time-point.
Fresh retina and ON samples (from the globe to the chiasm) were cleanly dissected without any contamination from surrounding tissue. In brief, after euthanization each globe was harvested from the mouse eye socket at the globe and optic nerve head (ONH) juncture. The globe was transferred to a clean petri dish and opened along the limbus. The retina was harvested from the posterior cup and the ONH removed using a trephine. For the ON, the skull was opened and each left and right ON between the globe and chiasm was harvested separately. All samples were collected in 1 ml of TRIzol (Invitrogen, Grand Island, NY) and homogenized using 5 mm steel beads in the TissueLyser LT (Qiagen, Valencia, CA) for five minutes at 50 oscillations/second. For phase separation 50 μl of BAN Phase Separation Reagent (Molecular Research Center, Cincinnati, Ohio) was added to the homogenized samples, and samples were centrifuged at 14,000 rpm for 15 minutes. The upper aqueous phase was transferred to an RNeasy mini column (Qiagen, Valencia, CA) and processed according to manufacturer’s protocol. The total RNA was re-suspended in 20 μl of nuclease-free water and quantified using the Thermo Scientific NanoDrop 2000 (NanoDrop products, Wilmington, DE). Integrity of the RNA was measured by calculating the RNA integrity number (RIN) using the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA), and samples with RIN values greater than 7 were used for microarray analysis.
Affymetrix gene chip arrays
For microarray analysis, 420 ng of RNA from each retina sample and 100 ng from each ON sample was pooled to a total of 2100 ng and 500 ng, respectively, and this was performed for each experimental and control group at each time point. Microarray hybridizations were performed at the University of Iowa DNA Core Facility. Total RNA (50 ng) was converted to SPIA (Single Primer Isothermal Amplification) amplified cDNA using the WT-Ovation Pico RNA Amplification System, v2 (NuGEN Technologies, San Carlos, CA). The amplified SPIA cDNA product was purified through a QIAGEN QIAquick PCR Purification column (QIAGEN). Five micrograms of this product were fragmented (average fragment size = 85 bases) and biotin labeled using the NuGEN FL-Ovation cDNA Biotin Module (NuGEN Technologies). The resulting biotin-labeled cDNA was mixed with Affymetrix eukaryotic hybridization buffer (Affymetrix, Inc., Santa Clara, CA), placed onto Affymetrix Mouse Gene 1.0 ST arrays and incubated at 45°C for 18 h with 60 rpm rotation in an Affymetrix Model 640 Genechip Hybridization Oven. Following hybridization, the arrays were washed, stained with streptavidin-phycoerythrin (Molecular Probes, Inc., Eugene, OR), and the signals were amplified with an anti-streptavidin antibody (Vector Laboratories, Inc., Burlingame, CA) using the Affymetrix Model 450 Fluidics Station. Arrays were scanned with the Affymetrix Model 3000 scanner with 7G upgrade, and data were collected using the using the GeneChip operating software (GCOS) v1.4.
Bioinformatic analysis of gene expression datasets
Microarray data were imported into the Partek Genomics Suite 6.6 software (Partek Inc., Louis, MO) and normalized based on the robust multi-array average (RMA). To further confirm the purity of each extracted tissue, we examined the expression of retina specific genes in the ON tissue and ON genes in the retina tissue. There was greater expression of retina specific markers: Rho, Nr2e3, Nrl and Crx in the retinal samples, while these genes were at the lower limits of detection in the ON samples. Conversely, there was greater expression of myelin marker genes Mag, Mobp, Mog, Mbp and Plp1 in the ON samples compared to the retina samples. In addition, we tested expression levels of Rho and Mbp by qPCR in both tissues (Additional file 6: Figure S4).
For the microarray analysis, the ONC samples were compared to the control samples and the microarray ratios and log2 fold values calculated at each time point. Up and down-regulated genes were identified for both datasets (retina and ON) with a selective filter of ≥1.5 and ≤ −1.5 fold values. The fold values were based on the q-value defined by the FDR analogue of the p <0.05. The genes were further analyzed using the publicly available bioinformatics software Database for Annotation, Visualization and Integrated Discovery (DAVID). Gene ontology (GO) based cluster analysis was performed to identify possible enrichment of genes (GO enrichment score calculated using a χ2 test) using differentially regulated genes per time point. The Fishers Exact p value is calculated by DAVID to identify GO enrichment based clusters and any p < 0.05 were considered to be significant based on the Benjamini multiple test correction and were enriched in the annotation category [124, 125]. Neuronal clusters were identified at specific time points and their genes graphed temporally under each GO category.
Identification of specific gene expression changes following ONC by Bayesian estimation of temporal regulation analysis
Analysis of time-course microarray data was performed using Bayesian Estimation of Temporal Regulation (BETR) analysis to account for any variations between individual samples within the pooled samples. The BETR expression probabilities were estimated using Probe Logarithmic Intensity Error with GC-background correction, a routine built into the Affymetrix Power Tools toolkit. Expression estimates for 11 housekeeping genes across all time-points were used to create a linear model between the average expression level and variance of each gene and housekeeping genes. This model was used to simulate additional readings for all estimated transcripts at each time point, which were subsequently used as additional inputs to the BETR  R package. From this algorithm output final BETR probabilities were determined for the total 18,786 genes identified within each of the retina and ON gene expression datasets (Additional file 3: Table S1 A, B). BETR probabilities ranged from 0 to 1 with 0 being the least significantly changed genes temporally and 1 being the most. Genes were then classified into frequency bins based on the range of BETR probabilities. Each frequency bin identified a range of 0.1 differences in BETR probabilities and bins ranged from the lowest 1 (BETR probability range of 0–0.1) to frequency bin 10 (BETR probability range of 0.9-1) (Additional file 3: Table S1A, B). We considered low BETR probabilities of frequency bins <5 to reflect no significant changes in gene expression, while high BETR probabilities (0.9-1.0) within frequency bin 10 to represent significant changes in gene expression over time.
Microarray confirmation through real-time qRT-PCR
Quantitative real-time PCR (qPCR) was used to validate the temporal gene microarray expression ratios for the differentially expressed genes. From the retinal data sets, two genes (Vsnl1 and Nrn1) were selected, while from the optic nerve data set, three genes were chosen (Syt1, Synpr and Nrn1) (Additional file 4: Table S2A). Reverse transcription was performed using the iScript™ cDNA synthesis kit (Bio-Rad Laboratories, Hercules, CA). Each sample (500 ng of RNA) was reverse transcribed as per manufacturer’s protocol. Gene specific primers were designed (MGI database) (Additional file 7: Table S3) and PCR products sequenced to confirm the specificity of each primer’s transcript (Genewiz Inc, NJ). qPCR was then performed in the BioRad CFX96 real time system (Bio-Rad Laboratories, Hercules, CA) using the SSoAdvanced™ SYBR Green master mix (Bio-Rad Laboratories, Hercules, CA). Cycles for the qRT-PCR were run as described in Additional file 8: Table S4. The cycle threshold (Ct) was assigned as log2 of PCR amplification. Technical duplicates for each sample were averaged, and each ONC and control samples were normalized to their own Gapdh Ct values. The difference between the ONC sample (experimental) and control sample ΔCt values was used to determine the relative fold change in each sample based on a 2 fold exponential. Control qRT-PCR reactions were performed in the absence of a cDNA template. Gene expression fold changes were graphed temporally for each dataset and compared to temporal microarray ratios from the Partek analysis. Statistical analysis for qPCR was performed using GraphPad Prism Software (Mean ± SEM) using one-way ANOVA (Tukey post hoc test) with a p < 0.05 considered statistically significant. Regression analysis was performed between qRT-PCR and microarray ratios, and the R2 coefficient of determination calculated and p < 0.05 were considered statistically significant (Additional file 4: Table S2 B).
IHC was performed to validate protein expression of qRT-PCR confirmed genes and to localize target proteins in the retina and ON. Whole eyes were harvested and fixed in 4% paraformaldehyde for 2 hours at room temperature. After fixation, the tissue was placed in 20% sucrose overnight at 4°C and embedded in optical cutting temperature (OCT) the next day. Sections (10 μm) were cut using a cryostat (Leica Biosystems - Richmond, IL). Cross sections of retina were transferred to Superfrost glass slides (Fisher Scientific - Chicago, IL). Slides were incubated in PBS for 10 minutes and blocked with SuperBlock™ Blocking Buffer (Fisher Scientific, Chicago, IL) at room temperature for one hour. Primary antibodies (Additional file 9: Table S5) were diluted in Superblock™. Each slide was probed with the respective primary antibody and incubated overnight at 4°C. Sections were then washed 3 times with PBS for 10 minutes each and incubated with Alexa Fluor secondary antibody (Additional file 9: Table S5) for 1 hour at room temperature. Slides were rinsed three times with PBS and mounted with ProLong® Gold anti-fade reagent with DAPI (Molecular Probes, Grand Island, NY). Sections were observed and captured using a Nikon Eclipse Ti-U Microscope (Nikon, Melville, NY) containing the Nuance Multispectral imaging system and analyzed using Adobe Photoshop CS5 software. Negative control images of retina and ON sections with no primary antibody are presented in Additional file 5: Figures S3 A-F.
Availability of supporting data
GEO Accession Number: Series GSE44708.
Central nervous system
Spinal cord injury
Optic nerve crush
Retinal ganglion cells
Bayesian Estimation of Temporal Regulation
Database for Annotation, Visualization, and Integrated Discovery
Nerve fiber layer
Ganglion cell layer
Days post crush
Optical cutting temperature
Phosphate buffer saline solution
Analysis of variance
Quantitative real time polymerase chain reaction
National center for biotechnology information
RNA integrity number
Schwartz M: Optic nerve crush: protection and regeneration. Brain Res Bull. 2004, 62 (6): 467-471. 10.1016/S0361-9230(03)00076-5.
Ohlsson M, Mattsson P, Svensson M: A temporal study of axonal degeneration and glial scar formation following a standardized crush injury of the optic nerve in the adult rat. Restor Neurol Neurosci. 2004, 22 (1): 1-10.
Magharious M, D’Onofrio PM, Hollander A, Zhu P, Chen J, Koeberle PD: Quantitative iTRAQ analysis of retinal ganglion cell degeneration after optic nerve crush. J Proteome Res. 2011, 10 (8): 3344-3362. 10.1021/pr2004055.
Wohlfart G: Degeneration and regeneration in the nervous system. Recent advances. World Neurol. 1961, 2: 187-198.
Windle WF: Regeneration of axons in the vertebrate central nervous system. Physiol Rev. 1956, 36 (4): 427-440.
Huber AB, Schwab ME: Nogo-A, a potent inhibitor of neurite outgrowth and regeneration. Biol Chem. 2000, 381 (5–6): 407-419.
Huber AB, Weinmann O, Brosamle C, Oertle T, Schwab ME: Patterns of Nogo mRNA and protein expression in the developing and adult rat and after CNS lesions. J Neurosci. 2002, 22 (9): 3553-3567.
Filbin MT: Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci. 2003, 4 (9): 703-713. 10.1038/nrn1195.
Tang S, Qiu J, Nikulina E, Filbin MT: Soluble myelin-associated glycoprotein released from damaged white matter inhibits axonal regeneration. Mol Cell Neurosci. 2001, 18 (3): 259-269. 10.1006/mcne.2001.1020.
Winzeler AM, Mandemakers WJ, Sun MZ, Stafford M, Phillips CT, Barres BA: The lipid sulfatide is a novel myelin-associated inhibitor of CNS axon outgrowth. J Neurosci. 2011, 31 (17): 6481-6492. 10.1523/JNEUROSCI.3004-10.2011.
Kopp MA, Liebscher T, Niedeggen A, Laufer S, Brommer B, Jungehulsing GJ, Strittmatter SM, Dirnagl U, Schwab JM: Small-molecule-induced Rho-inhibition: NSAIDs after spinal cord injury. Cell Tissue Res. 2012, 349 (1): 119-132. 10.1007/s00441-012-1334-7.
Sandvig A, Berry M, Barrett LB, Butt A, Logan A: Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration. Glia. 2004, 46 (3): 225-251. 10.1002/glia.10315.
Silver J, Miller JH: Regeneration beyond the glial scar. Nat Rev Neurosci. 2004, 5 (2): 146-156. 10.1038/nrn1326.
Lawson LJ, Frost L, Risbridger J, Fearn S, Perry VH: Quantification of the mononuclear phagocyte response to Wallerian degeneration of the optic nerve. J Neurocytol. 1994, 23 (12): 729-744. 10.1007/BF01268086.
Lazarov-Spiegler O, Rapalino O, Agranov G, Schwartz M: Restricted inflammatory reaction in the CNS: a key impediment to axonal regeneration?. Mol Med Today. 1998, 4 (8): 337-342. 10.1016/S1357-4310(98)01298-2.
Jaerve A, Muller HW: Chemokines in CNS injury and repair. Cell Tissue Res. 2012, 349 (1): 229-248. 10.1007/s00441-012-1427-3.
Monnier PP, D’Onofrio PM, Magharious M, Hollander AC, Tassew N, Szydlowska K, Tymianski M, Koeberle PD: Involvement of caspase-6 and caspase-8 in neuronal apoptosis and the regenerative failure of injured retinal ganglion cells. J Neurosci. 2011, 31 (29): 10494-10505. 10.1523/JNEUROSCI.0148-11.2011.
Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ: Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci. 1995, 36 (5): 774-786.
Li Y, Schlamp CL, Nickells RW: Experimental induction of retinal ganglion cell death in adult mice. Invest Ophthalmol Vis Sci. 1999, 40 (5): 1004-1008.
Li Y, Semaan SJ, Schlamp CL, Nickells RW: Dominant inheritance of retinal ganglion cell resistance to optic nerve crush in mice. BMC Neurosci. 2007, 8: 19-10.1186/1471-2202-8-19.
Barron KD, Dentinger MP, Krohel G, Easton SK, Mankes R: Qualitative and quantitative ultrastructural observations on retinal ganglion cell layer of rat after intraorbital optic nerve crush. J Neurocytol. 1986, 15 (3): 345-362. 10.1007/BF01611437.
Templeton JP, Nassr M, Vazquez-Chona F, Freeman-Anderson NE, Orr WE, Williams RW, Geisert EE: Differential response of C57BL/6J mouse and DBA/2J mouse to optic nerve crush. BMC Neurosci. 2009, 10: 90-10.1186/1471-2202-10-90.
Misantone LJ, Gershenbaum M, Murray M: Viability of retinal ganglion cells after optic nerve crush in adult rats. J Neurocytol. 1984, 13 (3): 449-465. 10.1007/BF01148334.
Bahr M: Live or let die - retinal ganglion cell death and survival during development and in the lesioned adult CNS. Trends Neurosci. 2000, 23 (10): 483-490. 10.1016/S0166-2236(00)01637-4.
Klocker N, Zerfowski M, Gellrich NC, Bahr M: Morphological and functional analysis of an incomplete CNS fiber tract lesion: graded crush of the rat optic nerve. J Neurosci Methods. 2001, 110 (1–2): 147-153.
Agudo M, Perez-Marin MC, Lonngren U, Sobrado P, Conesa A, Canovas I, Salinas-Navarro M, Miralles-Imperial J, Hallbook F, Vidal-Sanz M: Time course profiling of the retinal transcriptome after optic nerve transection and optic nerve crush. Mol Vis. 2008, 14: 1050-1063.
Tang Z, Arjunan P, Lee C, Li Y, Kumar A, Hou X, Wang B, Wardega P, Zhang F, Dong L, Zhang Y, Zhang SZ, Ding H, Fariss RN, Becker KG, Lennartsson J, Nagai N, Cao Y, Li X: Survival effect of PDGF-CC rescues neurons from apoptosis in both brain and retina by regulating GSK3beta phosphorylation. J Exp Med. 2010, 207 (4): 867-880. 10.1084/jem.20091704.
Lukas TJ, Wang AL, Yuan M, Neufeld AH: Early cellular signaling responses to axonal injury. Cell Commun Signal: CCS. 2009, 7: 5-10.1186/1478-811X-7-5.
Qu J, Jakobs TC: The time course of gene expression during reactive gliosis in the optic nerve. PLoS One. 2013, 8 (6): e67094-10.1371/journal.pone.0067094.
Sharma A, Pollett MA, Plant GW, Harvey AR: Changes in mRNA expression of class 3 semaphorins and their receptors in the adult rat retino-collicular system after unilateral optic nerve injury. Invest Ophthalmol Vis Sci. 2012, 53 (13): 8367-8377. 10.1167/iovs.12-10799.
Blaugrund E, Lavie V, Cohen I, Solomon A, Schreyer DJ, Schwartz M: Axonal regeneration is associated with glial migration: comparison between the injured optic nerves of fish and rats. J Comp Neurol. 1993, 330 (1): 105-112. 10.1002/cne.903300109.
Doster SK, Lozano AM, Aguayo AJ, Willard MB: Expression of the growth-associated protein GAP-43 in adult rat retinal ganglion cells following axon injury. Neuron. 1991, 6 (4): 635-647. 10.1016/0896-6273(91)90066-9.
Leon S, Yin Y, Nguyen J, Irwin N, Benowitz LI: Lens injury stimulates axon regeneration in the mature rat optic nerve. J Neurosci. 2000, 20 (12): 4615-4626.
Ridet JL, Malhotra SK, Privat A, Gage FH: Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997, 20 (12): 570-577. 10.1016/S0166-2236(97)01139-9.
Dibas A, Oku H, Fukuhara M, Kurimoto T, Ikeda T, Patil RV, Sharif NA, Yorio T: Changes in ocular aquaporin expression following optic nerve crush. Mol Vis. 2010, 16: 330-340.
Woldemussie E, Wijono M, Ruiz G: Muller cell response to laser-induced increase in intraocular pressure in rats. Glia. 2004, 47 (2): 109-119. 10.1002/glia.20000.
Parrilla-Reverter G, Agudo M, Nadal-Nicolas F, Alarcon-Martinez L, Jimenez-Lopez M, Salinas-Navarro M, Sobrado-Calvo P, Bernal-Garro JM, Villegas-Perez MP, Vidal-Sanz M: Time-course of the retinal nerve fibre layer degeneration after complete intra-orbital optic nerve transection or crush: a comparative study. Vis Res. 2009, 49 (23): 2808-2825. 10.1016/j.visres.2009.08.020.
Koeberle PD, Bahr M: Growth and guidance cues for regenerating axons: where have they gone?. J Neurobiol. 2004, 59 (1): 162-180. 10.1002/neu.10345.
Kermer P, Klocker N, Bahr M: Neuronal death after brain injury. Models, mechanisms, and therapeutic strategies in vivo. Cell Tissue Res. 1999, 298 (3): 383-395. 10.1007/s004410050061.
Koeberle PD, Gauldie J, Ball AK: Effects of adenoviral-mediated gene transfer of interleukin-10, interleukin-4, and transforming growth factor-beta on the survival of axotomized retinal ganglion cells. Neuroscience. 2004, 125 (4): 903-920. 10.1016/S0306-4522(03)00398-1.
Kipnis J, Yoles E, Schori H, Hauben E, Shaked I, Schwartz M: Neuronal survival after CNS insult is determined by a genetically encoded autoimmune response. J Neurosci. 2001, 21 (13): 4564-4571.
Isenmann S, Wahl C, Krajewski S, Reed JC, Bahr M: Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci. 1997, 9 (8): 1763-1772. 10.1111/j.1460-9568.1997.tb01534.x.
Kermer P, Ankerhold R, Klocker N, Krajewski S, Reed JC, Bahr M: Caspase-9: involvement in secondary death of axotomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res. 2000, 85 (1–2): 144-150.
Kermer P, Klocker N, Labes M, Bahr M: Inhibition of CPP32-like proteases rescues axotomized retinal ganglion cells from secondary cell death in vivo. J Neurosci. 1998, 18 (12): 4656-4662.
Kikuchi M, Tenneti L, Lipton SA: Role of p38 mitogen-activated protein kinase in axotomy-induced apoptosis of rat retinal ganglion cells. J Neurosci. 2000, 20 (13): 5037-5044.
Galindo-Romero C, Aviles-Trigueros M, Jimenez-Lopez M, Valiente-Soriano FJ, Salinas-Navarro M, Nadal-Nicolas F, Villegas-Perez MP, Vidal-Sanz M, Agudo-Barriuso M: Axotomy-induced retinal ganglion cell death in adult mice: quantitative and topographic time course analyses. Exp Eye Res. 2011, 92 (5): 377-387. 10.1016/j.exer.2011.02.008.
Kim BJ, Braun TA, Wordinger RJ, Clark AF: Progressive morphological changes and impaired retinal function associated with temporal regulation of gene expression after retinal ischemia/reperfusion injury in mice. Mol Neurodegener. 2013, 8: 21-10.1186/1750-1326-8-21.
Xia Y, Chen J, Xiong L, Liu J, Liu X, Ma L, Zhang Q, You C, Chen J, Liu X, Wang X, Ju Y: Retinal whole genome microarray analysis and early morphological changes in the optic nerves of monkeys after an intraorbital nerve irradiated injury. Mol Vis. 2011, 17: 2920-2933.
Jehle T, Dimitriu C, Auer S, Knoth R, Vidal-Sanz M, Gozes I, Lagreze WA: The neuropeptide NAP provides neuroprotection against retinal ganglion cell damage after retinal ischemia and optic nerve crush. Albrecht Von Graefes Arch Klin Exp Ophthalmol. 2008, 246 (9): 1255-1263. 10.1007/s00417-007-0746-7.
Agudo M, Perez-Marin MC, Sobrado-Calvo P, Lonngren U, Salinas-Navarro M, Canovas I, Nadal-Nicolas FM, Miralles-Imperial J, Hallbook F, Vidal-Sanz M: Immediate upregulation of proteins belonging to different branches of the apoptotic cascade in the retina after optic nerve transection and optic nerve crush. Invest Ophthalmol Vis Sci. 2009, 50 (1): 424-431.
Goldenberg-Cohen N, Dratviman-Storobinsky O, El Dadon Bar S, Cheporko Y, Hochhauser E: Protective effect of bax ablation against cell loss in the retinal ganglion layer induced by optic nerve crush in transgenic mice. J Neuroophthalmol. 2011, 31 (4): 331-338. 10.1097/WNO.0b013e318227e4fb.
Haverkamp S, Inta D, Monyer H, Wassle H: Expression analysis of green fluorescent protein in retinal neurons of four transgenic mouse lines. Neuroscience. 2009, 160 (1): 126-139. 10.1016/j.neuroscience.2009.01.081.
Raymond ID, Vila A, Huynh UC, Brecha NC: Cyan fluorescent protein expression in ganglion and amacrine cells in a thy1-CFP transgenic mouse retina. Mol Vis. 2008, 14: 1559-1574.
Masland RH: Neuronal diversity in the retina. Curr Opin Neurobiol. 2001, 11 (4): 431-436. 10.1016/S0959-4388(00)00230-0.
Kim CY, Kuehn MH, Clark AF, Kwon YH: Gene expression profile of the adult human retinal ganglion cell layer. Mol Vis. 2006, 12: 1640-1648.
Villegas-Perez MP, Vidal-Sanz M, Rasminsky M, Bray GM, Aguayo AJ: Rapid and protracted phases of retinal ganglion cell loss follow axotomy in the optic nerve of adult rats. J Neurobiol. 1993, 24 (1): 23-36. 10.1002/neu.480240103.
Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, Nieto-Lopez L, Canovas-Martinez I, Salinas-Navarro M, Vidal-Sanz M, Agudo M: Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerve-injured retinas. Invest Ophthalmol Vis Sci. 2009, 50 (8): 3860-3868. 10.1167/iovs.08-3267.
Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ: Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci. 1994, 14 (7): 4368-4374.
Aryee MJ, Gutierrez-Pabello JA, Kramnik I, Maiti T, Quackenbush J: An improved empirical bayes approach to estimating differential gene expression in microarray time-course data: BETR (Bayesian Estimation of Temporal Regulation). BMC Bioinforma. 2009, 10: 409-10.1186/1471-2105-10-409.
Cantallops I, Haas K, Cline HT: Postsynaptic CPG15 promotes synaptic maturation and presynaptic axon arbor elaboration in vivo. Nat Neurosci. 2000, 3 (10): 1004-1011. 10.1038/79823.
Carpenter S: Proximal axonal enlargement in motor neuron disease. Neurology. 1968, 18 (9): 841-851. 10.1212/WNL.18.9.841.
Delisle MB, Carpenter S: Neurofibrillary axonal swellings and amyotrophic lateral sclerosis. J Neurol Sci. 1984, 63 (2): 241-250. 10.1016/0022-510X(84)90199-0.
Ishii T, Haga S, Tokutake S: Presence of neurofilament protein in Alzheimer’s neurofibrillary tangles (ANT). An immunofluorescent study. Acta Neuropathol. 1979, 48 (2): 105-112. 10.1007/BF00691151.
Nukina N, Kosik KS, Selkoe DJ: Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein. Proc Natl Acad Sci U S A. 1987, 84 (10): 3415-3419. 10.1073/pnas.84.10.3415.
Hill WD, Arai M, Cohen JA, Trojanowski JQ: Neurofilament mRNA is reduced in Parkinson’s disease substantia nigra pars compacta neurons. J Comp Neurol. 1993, 329 (3): 328-336. 10.1002/cne.903290304.
Fabrizi GM, Cavallaro T, Angiari C, Bertolasi L, Cabrini I, Ferrarini M, Rizzuto N: Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology. 2004, 62 (8): 1429-1431. 10.1212/01.WNL.0000120664.07186.3C.
Bigio EH, Lipton AM, White CL, Dickson DW, Hirano A: Frontotemporal and motor neurone degeneration with neurofilament inclusion bodies: additional evidence for overlap between FTD and ALS. Neuropathol Appl Neurobiol. 2003, 29 (3): 239-253. 10.1046/j.1365-2990.2003.00466.x.
Cairns NJ, Perry RH, Jaros E, Burn D, McKeith IG, Lowe JS, Holton J, Rossor MN, Skullerud K, Duyckaerts C, Cruz-Sanchez FF, Lantos PL: Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett. 2003, 341 (3): 177-180. 10.1016/S0304-3940(03)00100-9.
Josephs KA, Holton JL, Rossor MN, Braendgaard H, Ozawa T, Fox NC, Petersen RC, Pearl GS, Ganguly M, Rosa P, Laursen H, Parisi JE, Waldemar G, Quinn NP, Dickson DW, Revesz T: Neurofilament inclusion body disease: a new proteinopathy?. Brain. 2003, 126 (Pt 10): 2291-2303.
Asbury AK, Gale MK, Cox SC, Baringer JR, Berg BO: Giant axonal neuropathy–a unique case with segmental neurofilamentous masses. Acta Neuropathol. 1972, 20 (3): 237-247. 10.1007/BF00686905.
Medori R, Autilio-Gambetti L, Monaco S, Gambetti P: Experimental diabetic neuropathy: impairment of slow transport with changes in axon cross-sectional area. Proc Natl Acad Sci U S A. 1985, 82 (22): 7716-7720. 10.1073/pnas.82.22.7716.
Medori R, Jenich H, Autilio-Gambetti L, Gambetti P: Experimental diabetic neuropathy: similar changes of slow axonal transport and axonal size in different animal models. J Neurosci. 1988, 8 (5): 1814-1821.
Perrot R, Berges R, Bocquet A, Eyer J: Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol. 2008, 38 (1): 27-65. 10.1007/s12035-008-8033-0.
Huang X, Kong W, Zhou Y, Gregori G: Distortion of axonal cytoskeleton: an early sign of glaucomatous damage. Invest Ophthalmol Vis Sci. 2011, 52 (6): 2879-2888. 10.1167/iovs.10-5929.
Ivanov D, Dvoriantchikova G, Nathanson L, McKinnon SJ, Shestopalov VI: Microarray analysis of gene expression in adult retinal ganglion cells. FEBS Lett. 2006, 580 (1): 331-335. 10.1016/j.febslet.2005.12.017.
Farkas RH, Qian J, Goldberg JL, Quigley HA, Zack DJ: Gene expression profiling of purified rat retinal ganglion cells. Invest Ophthalmol Vis Sci. 2004, 45 (8): 2503-2513. 10.1167/iovs.03-1391.
Grabs D, Bergmann M, Schuster T, Fox PA, Brich M, Gratz M: Differential expression of synaptophysin and synaptoporin during pre- and postnatal development of the rat hippocampal network. Eur J Neurosci. 1994, 6 (11): 1765-1771. 10.1111/j.1460-9568.1994.tb00569.x.
Singec I, Knoth R, Ditter M, Hagemeyer CE, Rosenbrock H, Frotscher M, Volk B: Synaptic vesicle protein synaptoporin is differently expressed by subpopulations of mouse hippocampal neurons. J Comp Neurol. 2002, 452 (2): 139-153. 10.1002/cne.10371.
Sun T, Xiao HS, Zhou PB, Lu YJ, Bao L, Zhang X: Differential expression of synaptoporin and synaptophysin in primary sensory neurons and up-regulation of synaptoporin after peripheral nerve injury. Neuroscience. 2006, 141 (3): 1233-1245. 10.1016/j.neuroscience.2006.05.010.
Greif KF, Asabere N, Lutz GJ, Gallo G: Synaptotagmin-1 promotes the formation of axonal filopodia and branches along the developing axons of forebrain neurons. Dev Neurobiol. 2013, 73 (1): 27-44. 10.1002/dneu.22033.
Malarkey EB, Parpura V: Temporal characteristics of vesicular fusion in astrocytes: examination of synaptobrevin 2-laden vesicles at single vesicle resolution. J Physiol. 2011, 589 (Pt 17): 4271-4300.
Jeon CJ, Strettoi E, Masland RH: The major cell populations of the mouse retina. J Neurosci. 1998, 18 (21): 8936-8946.
Quina LA, Pak W, Lanier J, Banwait P, Gratwick K, Liu Y, Velasquez T, O’Leary DD, Goulding M, Turner EE: Brn3a-expressing retinal ganglion cells project specifically to thalamocortical and collicular visual pathways. J Neurosci. 2005, 25 (50): 11595-11604. 10.1523/JNEUROSCI.2837-05.2005.
Johnson TV, Martin KR: Development and characterization of an adult retinal explant organotypic tissue culture system as an in vitro intraocular stem cell transplantation model. Invest Ophthalmol Vis Sci. 2008, 49 (8): 3503-3512. 10.1167/iovs.07-1601.
Fujino T, Wu Z, Lin WC, Phillips MA, Nedivi E: cpg15 and cpg15-2 constitute a family of activity-regulated ligands expressed differentially in the nervous system to promote neurite growth and neuronal survival. J Comp Neurol. 2008, 507 (5): 1831-1845. 10.1002/cne.21649.
Kigerl KA, McGaughy VM, Popovich PG: Comparative analysis of lesion development and intraspinal inflammation in four strains of mice following spinal contusion injury. J Comp Neurol. 2006, 494 (4): 578-594. 10.1002/cne.20827.
Libby RT, Li Y, Savinova OV, Barter J, Smith RS, Nickells RW, John SW: Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005, 1 (1): 17-26. 10.1371/journal.pgen.0010017.
Montalban-Soler L, Alarcon-Martinez L, Jimenez-Lopez M, Salinas-Navarro M, Galindo-Romero C, Bezerra de Sa F, Garcia-Ayuso D, Aviles-Trigueros M, Vidal-Sanz M, Agudo-Barriuso M, Villegas-Pérez MP: Retinal compensatory changes after light damage in albino mice. Mol Vis. 2012, 18: 675-693.
Garcia-Ayuso D, Salinas-Navarro M, Agudo-Barriuso M, Alarcon-Martinez L, Vidal-Sanz M, Villegas-Perez MP: Retinal ganglion cell axonal compression by retinal vessels in light-induced retinal degeneration. Mol Vis. 2011, 17: 1716-1733.
McCurley AT, Callard GV: Time course analysis of gene expression patterns in zebrafish eye during optic nerve regeneration. J Exp Neurosci. 2010, 2010 (4): 17-33.
Agudo-Barriuso M, Lahoz A, Nadal-Nicolas FM, Sobrado-Calvo P, Piquer-Gil M, Diaz-Llopis M, Vidal-Sanz M, Mullor JL: Metabolomic changes in the rat retina after optic nerve crush. Invest Ophthalmol Vis Sci. 2013, 54 (6): 4249-4259. 10.1167/iovs.12-11451.
Liedtke T, Naskar R, Eisenacher M, Thanos S: Transformation of adult retina from the regenerative to the axonogenesis state activates specific genes in various subsets of neurons and glial cells. Glia. 2007, 55 (2): 189-201. 10.1002/glia.20447.
Munguba GC, Geisert EE, Williams RW, Tapia ML, Lam DK, Bhattacharya SK, Lee RK: Effects of glaucoma on Chrna6 expression in the retina. Curr Eye Res. 2013, 38 (1): 150-157. 10.3109/02713683.2012.724512.
Yuan A, Rao MV, Sasaki T, Chen Y, Kumar A, Veeranna , Liem RK, Eyer J, Peterson AC, Julien JP, Nixon RA: Alpha-internexin is structurally and functionally associated with the neurofilament triplet proteins in the mature CNS. J Neurosci. 2006, 26 (39): 10006-10019. 10.1523/JNEUROSCI.2580-06.2006.
Kielczewski JL, Pease ME, Quigley HA: The effect of experimental glaucoma and optic nerve transection on amacrine cells in the rat retina. Invest Ophthalmol Vis Sci. 2005, 46 (9): 3188-3196. 10.1167/iovs.05-0321.
Kirsch M, Trautmann N, Ernst M, Hofmann HD: Involvement of gp130-associated cytokine signaling in Muller cell activation following optic nerve lesion. Glia. 2010, 58 (7): 768-779. 10.1002/glia.20961.
Aldskogius H, Kozlova EN: Central neuron-glial and glial-glial interactions following axon injury. Prog Neurobiol. 1998, 55 (1): 1-26. 10.1016/S0301-0082(97)00093-2.
Bernstein HG, Baumann B, Danos P, Diekmann S, Bogerts B, Gundelfinger ED, Braunewell KH: Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain. J Neurocytol. 1999, 28 (8): 655-662. 10.1023/A:1007056731551.
Braunewell KH, Klein-Szanto AJ: Visinin-like proteins (VSNLs): interaction partners and emerging functions in signal transduction of a subfamily of neuronal Ca2 + − sensor proteins. Cell Tissue Res. 2009, 335 (2): 301-316. 10.1007/s00441-008-0716-3.
De Raad S, Comte M, Nef P, Lenz SE, Gundelfinger ED, Cox JA: Distribution pattern of three neural calcium-binding proteins (NCS-1, VILIP and recoverin) in chicken, bovine and rat retina. Histochem J. 1995, 27 (7): 524-535. 10.1007/BF02388752.
Yao JJ, Gao XF, Chow CW, Zhan XQ, Hu CL, Mei YA: Neuritin activates insulin receptor pathway to up-regulate Kv4.2-mediated transient outward K + current in rat cerebellar granule neurons. J Biol Chem. 2012, 287 (49): 41534-41545. 10.1074/jbc.M112.390260.
Nedivi E, Wu GY, Cline HT: Promotion of dendritic growth by CPG15, an activity-induced signaling molecule. Science. 1998, 281 (5384): 1863-1866.
Fujino T, Leslie JH, Eavri R, Chen JL, Lin WC, Flanders GH, Borok E, Horvath TL, Nedivi E: CPG15 regulates synapse stability in the developing and adult brain. Genes Dev. 2011, 25 (24): 2674-2685. 10.1101/gad.176172.111.
Naeve GS, Ramakrishnan M, Kramer R, Hevroni D, Citri Y, Theill LE: Neuritin: a gene induced by neural activity and neurotrophins that promotes neuritogenesis. Proc Natl Acad Sci U S A. 1997, 94 (6): 2648-2653. 10.1073/pnas.94.6.2648.
Nedivi E, Fieldust S, Theill LE, Hevron D: A set of genes expressed in response to light in the adult cerebral cortex and regulated during development. Proc Natl Acad Sci U S A. 1996, 93 (5): 2048-2053. 10.1073/pnas.93.5.2048.
Javaherian A, Cline HT: Coordinated motor neuron axon growth and neuromuscular synaptogenesis are promoted by CPG15 in vivo. Neuron. 2005, 45 (4): 505-512. 10.1016/j.neuron.2004.12.051.
Cappelletti G, Galbiati M, Ronchi C, Maggioni MG, Onesto E, Poletti A: Neuritin (cpg15) enhances the differentiating effect of NGF on neuronal PC12 cells. J Neurosci Res. 2007, 85 (12): 2702-2713. 10.1002/jnr.21235.
Fainzilber M, Budnik V, Segal RA, Kreutz MR: From synapse to nucleus and back again–communication over distance within neurons. J Neurosci. 2011, 31 (45): 16045-16048. 10.1523/JNEUROSCI.4006-11.2011.
Li JY, Dahlstrom A: Axonal transport of synaptic vesicle proteins in the rat optic nerve. J Neurobiol. 1997, 32 (2): 237-250. 10.1002/(SICI)1097-4695(199702)32:2<237::AID-NEU8>3.0.CO;2-9.
Kwon KB, Kim JS, Chang BJ: Translocational changes of localization of synapsin in axonal sprouts of regenerating rat sciatic nerves after ligation crush injury. J Vet Sci. 2000, 1 (1): 1-9.
Morfini G, Szebenyi G, Elluru R, Ratner N, Brady ST: Glycogen synthase kinase 3 phosphorylates kinesin light chains and negatively regulates kinesin-based motility. EMBO J. 2002, 21 (3): 281-293. 10.1093/emboj/21.3.281.
Kochubey O, Lou X, Schneggenburger R: Regulation of transmitter release by Ca(2+) and synaptotagmin: insights from a large CNS synapse. Trends Neurosci. 2011, 34 (5): 237-246. 10.1016/j.tins.2011.02.006.
Chen YA, Scheller RH: SNARE-mediated membrane fusion. Nat Rev Mol Cell Biol. 2001, 2 (2): 98-106. 10.1038/35052017.
Martens S, Kozlov MM, McMahon HT: How synaptotagmin promotes membrane fusion. Science. 2007, 316 (5828): 1205-1208. 10.1126/science.1142614.
Vrljic M, Strop P, Ernst JA, Sutton RB, Chu S, Brunger AT: Molecular mechanism of the synaptotagmin-SNARE interaction in Ca2 + −triggered vesicle fusion. Nat Struct Mol Biol. 2010, 17 (3): 325-331. 10.1038/nsmb.1764.
Vennekate W, Schroder S, Lin CC, van den Bogaart G, Grunwald M, Jahn R, Walla PJ: Cis- and trans-membrane interactions of synaptotagmin-1. Proc Natl Acad Sci U S A. 2012, 109 (27): 11037-11042. 10.1073/pnas.1116326109.
Marqueze-Pouey B, Wisden W, Malosio ML, Betz H: Differential expression of synaptophysin and synaptoporin mRNAs in the postnatal rat central nervous system. J Neurosci. 1991, 11 (11): 3388-3397.
Bergmann M, Schuster T, Grabs D, Marqueze-Pouey B, Betz H, Traurig H, Mayerhofer A, Gratzl M: Synaptophysin and synaptoporin expression in the developing rat olfactory system. Brain Res Dev Brain Res. 1993, 74 (2): 235-244. 10.1016/0165-3806(93)90009-Y.
Brandstatter JH, Lohrke S, Morgans CW, Wassle H: Distributions of two homologous synaptic vesicle proteins, synaptoporin and synaptophysin, in the mammalian retina. J Comp Neurol. 1996, 370 (1): 1-10. 10.1002/(SICI)1096-9861(19960617)370:1<1::AID-CNE1>3.0.CO;2-7.
Khaitovich P, Muetzel B, She X, Lachmann M, Hellmann I, Dietzsch J, Steigele S, Do HH, Weiss G, Enard W, Heissig F, Arendt T, Nieselt-Struwe K, Eichler EE, Pääbo S: Regional patterns of gene expression in human and chimpanzee brains. Genome Res. 2004, 14 (8): 1462-1473. 10.1101/gr.2538704.
Khaitovich P, Weiss G, Lachmann M, Hellmann I, Enard W, Muetzel B, Wirkner U, Ansorge W, Pääbo S: A neutral model of transcriptome evolution. PLoS Biol. 2004, 2 (5): E132-10.1371/journal.pbio.0020132.
Sandberg R, Yasuda R, Pankratz DG, Carter TA, Del Rio JA, Wodicka L, Mayford M, Lockhart DJ, Barlow C: Regional and strain-specific gene expression mapping in the adult mouse brain. Proc Natl Acad Sci U S A. 2000, 97 (20): 11038-11043. 10.1073/pnas.97.20.11038.
Dietz JA, Li Y, Chung LM, Yandell BS, Schlamp CL, Nickells RW: Rgcs1, a dominant QTL that affects retinal ganglion cell death after optic nerve crush in mice. BMC Neurosci. 2008, 9: 74-10.1186/1471-2202-9-74.
Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA: DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4 (5): 3-10.1186/gb-2003-4-5-p3.
Ryan JC, Morey JS, Bottein MY, Ramsdell JS, Van Dolah FM: Gene expression profiling in brain of mice exposed to the marine neurotoxin ciguatoxin reveals an acute anti-inflammatory, neuroprotective response. BMC Neurosci. 2010, 11: 107-10.1186/1471-2202-11-107.
This study was supported by a grant (W81XWH-10-2-0003) from the Department of Defense.
The authors declare that they have no competing interests.
TPS performed the RNA extraction, tissue sample staining, bioinformatics Partek and DAVID analysis, qRT-PCR and correlation analysis of all optic nerve crush samples; including writing all sections of the manuscript. CM and YL both performed the optic nerve crush and subsequently CM did the Nissl stained retinal flat mount neuron survival analysis while YL prepared the immunohistochemistry sections. BF processed image data. DT performed differential expression analysis and AW analyzed the microarray data using the BETR analysis. AFC, RJW and TAB conceived the study, actively participated in the design and coordination of the study, reviewed all the data, and helped draft the manuscript. All authors read and approved the final manuscript.
Electronic supplementary material
Authors’ original submitted files for images
About this article
- Central nervous system
- Optic nerve crush
- Retinal ganglion cell
- Gene expression